Abstract
Since the discovery of liposomes by Alec Bangham in mid-1960s, these phospholipid vesicles have been widely used as pharmaceutical carriers. Liposomes have been extensively studied in the vaccine delivery field as a carrier and an immune stimulating agent. Liposomes are usually formulated as nanoparticles, mimicking the properties of pathogens, and have the ability to induce humoral and cell-mediated immune responses. In this review, we focused on modern nanotechnology-based approaches for the improvement of liposomal vaccine delivery systems. Topics such as sizedependent uptake, processing and activation of antigen presenting cells, targeting liposomes and route of administration are discussed.
Keywords: Administration route, bilosome, liposome, niosome, size-dependent immunity, vaccine delivery, virosome.
Current Topics in Medicinal Chemistry
Title:Liposomes as Nanovaccine Delivery Systems
Volume: 14 Issue: 9
Author(s): Khairunnisa Abdul Ghaffar, Ashwini Kumar Giddam, Mehfuz Zaman, Mariusz Skwarczynski and Istvan Toth
Affiliation:
Keywords: Administration route, bilosome, liposome, niosome, size-dependent immunity, vaccine delivery, virosome.
Abstract: Since the discovery of liposomes by Alec Bangham in mid-1960s, these phospholipid vesicles have been widely used as pharmaceutical carriers. Liposomes have been extensively studied in the vaccine delivery field as a carrier and an immune stimulating agent. Liposomes are usually formulated as nanoparticles, mimicking the properties of pathogens, and have the ability to induce humoral and cell-mediated immune responses. In this review, we focused on modern nanotechnology-based approaches for the improvement of liposomal vaccine delivery systems. Topics such as sizedependent uptake, processing and activation of antigen presenting cells, targeting liposomes and route of administration are discussed.
Export Options
About this article
Cite this article as:
Ghaffar Abdul Khairunnisa, Giddam Kumar Ashwini, Zaman Mehfuz, Skwarczynski Mariusz and Toth Istvan, Liposomes as Nanovaccine Delivery Systems, Current Topics in Medicinal Chemistry 2014; 14 (9) . https://dx.doi.org/10.2174/1568026614666140329232757
DOI https://dx.doi.org/10.2174/1568026614666140329232757 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
Call for Papers in Thematic Issues
Adaptogens—History and Future Perspectives
Adaptogens are pharmacologically active compounds or plant extracts that are associated with the ability to enhance the body’s stability against stress. The intake of adaptogens is associated not only with a better ability to adapt to stress and maintain or normalise metabolic functions but also with better mental and physical ...read more
AlphaFold in Medicinal Chemistry: Opportunities and Challenges
AlphaFold, a groundbreaking AI tool for protein structure prediction, is revolutionizing drug discovery. Its near-atomic accuracy unlocks new avenues for designing targeted drugs and performing efficient virtual screening. However, AlphaFold's static predictions lack the dynamic nature of proteins, crucial for understanding drug action. This is especially true for multi-domain proteins, ...read more
Artificial intelligence for Natural Products Discovery and Development
Our approach involves using computational methods to predict the potential therapeutic benefits of natural products by considering factors such as drug structure, targets, and interactions. We also employ multitarget analysis to understand the role of drug targets in disease pathways. We advocate for the use of artificial intelligence in predicting ...read more
Big Data in Biomedicine: Integrating Bioinformatics and Clinical Databases
The rapid advancement of big data technologies is transforming biomedicine by integrating bioinformatics and clinical databases to drive precision medicine and innovative healthcare solutions. This thematic issue explores the intersection of computational biology, machine learning, and biomedical informatics, highlighting how large-scale data analysis enhances disease diagnosis, biomarker discovery, and personalized ...read more

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Multimodal Nanomedicine Strategies for Targeting Cancer Cells as well as Cancer Stem Cell Signalling Mechanisms
Mini-Reviews in Medicinal Chemistry Apoptosis-Inducing Effects of Amaryllidaceae Alkaloids
Current Medicinal Chemistry The PTEN/PI3K/AKT Signalling Pathway in Cancer, Therapeutic Implications
Current Cancer Drug Targets Amyloidogenicity of p53: A Hidden Link Between Protein Misfolding and Cancer
Current Protein & Peptide Science Advances in Immunotherapy of Chronic Myeloid Leukemia CML
Current Cancer Drug Targets Exploration and Exploitation of the Yeast Volatilome
Current Metabolomics The Role of FTO in Tumors and Its Research Progress
Current Medicinal Chemistry Resveratrol as a Chemopreventive Agent: A Promising Molecule for Fighting Cancer
Current Drug Targets STAT3 Regulation of Glioblastoma Pathogenesis
Current Molecular Medicine Antiangiogenic Therapy
Current Pharmaceutical Design The Application of the RNA Interference Technologies for KRAS: Current Status, Future Perspective and Associated Challenges
Current Topics in Medicinal Chemistry PCSK9 as a New Player in Cancer: New Opportunity or Red Herring?
Current Medicinal Chemistry Aberrant Expression of MicroRNAs in B-cell Lymphomas
MicroRNA Immunomodulatory Drugs (IMiDs) in Multiple Myeloma
Current Cancer Drug Targets Synthesis of Phosphorylated Derivatives of 2', 3'-O-Isopropylidene Adenosine and their In Ovo Antiviral Activity
Letters in Drug Design & Discovery Cerebrospinal Fluid Proteomes: From Neural Development to Neurodegenerative Diseases
Current Proteomics The Role of Bone Morphogenetic Protein 4 in Lung Diseases
Current Molecular Medicine Clinical Effectiveness and Cost-effectiveness of Target Therapies for Adult Patients with Locally Advanced or Metastatic Non-small Cell Lung Cancer: A Systematic Review
Current Cancer Drug Targets Plasma-Free Amino Acid Profiling of Nasal Polyposis Patients
Combinatorial Chemistry & High Throughput Screening On the Cytotoxicity of Chiral Ruthenium Complexes Containing Sulfur Amino Acids against Breast Tumor Cells (MDA-231 and MCF-7)
Anti-Cancer Agents in Medicinal Chemistry